New shot aims to tame bleeding disorder in small trial
NCT ID NCT07640893
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial tests an injection called SR604 in 24 adults with von Willebrand disease, a bleeding disorder. The goal is to see if it safely reduces the number of bleeding episodes. Participants receive multiple doses, and researchers track bleeding rates and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SR604 injection
What this could lead to
If successful, this could provide a new treatment option to control bleeding episodes in people with von Willebrand disease.
What could go wrong
This is an early Phase 2 trial with only 24 participants, so results may not apply to everyone. The treatment may not reduce bleeding as hoped or could have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, China
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, China
-
Jinan Central Hospital
RECRUITINGJinan, China
-
North China University of Science and Technology Affiliated Hospital
RECRUITINGTangshan, China
-
The First Affiliated Hospital of Guangxi Medical University
RECRUITINGNanning, China
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, China
-
The First Affiliated Hospital of University of Science and Technology of China
RECRUITINGHefei, China
-
The Second Hospital of Shanxi Medical University
RECRUITINGTaiyuan, China
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, China